The Second Affiliated Hospital of Soochow University
Suzhou, Jinagsu, 215004, China
Location status: Recruiting
NCT Number: NCT06542263
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice, significantly increasing the risks of death, stroke, heart failure, cognitive impairment, and dementia, thus severely impacting patients' quality of life. However, for AF patients with concomitant cardiovascular risk factors, particularly those with obstructive sleep apnea (OSA), the success rate of catheter ablation is significantly reduced. Continuous positive airway pressure (CPAP) is currently an effective treatment for OSA, effectively correcting nocturnal intermittent hypoxia and fragmented sleep caused by OSA. However, the effect of CPAP therapy on AF recurrence in patients with OSA undergoing catheter ablation remains controversial. Faced with conflicting research findings, our team recently conducted a meta-analysis (registration number CRD42023398588) to assess the impact of CPAP on AF recurrence post catheter ablation in patients with AF and OSA, suggesting that CPAP significantly reduces AF recurrence post catheter ablation (RR = 0.58, P < 0.01). However, considering the limited number of included studies, potential bias risks, and confounding factors, our meta-analysis results await further confirmation through real-world studies by our team. Therefore, our team plans to conduct further research on the impact of CPAP on AF recurrence post catheter ablation in patients with moderate to severe OSA, aiming to provide clinical guidance for the treatment of AF in patients with moderate to severe OSA.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Suzhou, Jinagsu, 215004, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For the non-CPAP group, the intervention includes catheter ablation and conventional treatment for AF combined with OSA; For the CPAP group, the intervention includes catheter ablation and CPAP treatment for AF combined with OSA
Time frame: At 3, 6, 9, and 12 months after AF ablation
AF recurrence after ablation via Surface electrocardiogram and 24-hour dynamic electrocardiogram examination. If there are symptoms, seek medical attention at any time for electrocardiogram examination
Time frame: At 3, 6, 9, and 12 months after AF ablation
AF burden after ablation via 24-hour dynamic electrocardiogram examination AF burden after ablation via 24-hour dynamic electrocardiogram examinatio AF burden after ablation via 24-hour dynamic electrocardiogram examinatio
Time frame: At 3, 6, 9, and 12 months after AF ablation
The recurrence of AF after combination with antiarrhythmic drugs via Surface electrocardiogram and 24-hour dynamic electrocardiogram examination. If there are symptoms, seek medical attention at any time for electrocardiogram examination
Time frame: At 3, 6, 9, and 12 months after AF ablation
AF burden after combination with antiarrhythmic drugs via 24-hour dynamic electrocardiogram examinatio
Time frame: At 3 and 12 months after AF ablation
SF-36 with standard scores ranging from 0 to 100. The higher the score, the better the health status
Time frame: At 3 and 12 months after AF ablation
Euro-QoL5D survey questionnaire is between 0 and 100, with higher scores indicating better health status
Contact information is provided by the study sponsor or research team.
Second Affiliated Hospital of Soochow University
Other
Clinical Study on the Effect of Continuous Positive Airway Pressure Ventilation on Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Atrial Fibrillation and Obstructive Sleep Apnea
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04814420
Apnea, Arrhythmias, Cardiac
New Orleans, Louisiana, United States
View Trial DetailsNCT06263608
Apnea, Arrhythmias, Cardiac
Edegem, Belgium
View Trial DetailsNCT04005508
Apnea, Arrhythmias, Cardiac
Singapore
View Trial DetailsNCT05221229
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, West Midlands, United Kingdom
View Trial Details